James Shapiro, was born in Leeds, England and obtained his medical degree at the University of Newcastle upon Tyne. He is currently a Canadian Research Chair in transplantation and the Director of the Clinical Islet Transplant Program at the University of Alberta in Edmonton, Canada. He is Professor of Surgery, Medicine and Surgical Oncology.
Shapiro is known for developing the Edmonton Protocol, an islet transplantation technique which has allowed many severe diabetics to stop taking insulin entirely, although the duration of this insulin independence does vary. The Edmonton Protocol is considered a major advancement from earlier transplantation efforts, and has regenerated much interest and research into establishing islet transplantation as a regular treatment modality for diabetes. One of the key components included a successful cocktail of non-corticosteroid immunosuppressive drugs, necessary for the prevention of allogeneic graft rejection.
James is the recipient of several prestigious awards, including the Hunterian Medal from the Royal College of Surgeons of England, the Paul E. Lacy Gold Medal, the Gold Medal in Surgery from the Royal College of Physicians and Surgeons of Canada, the Governor General’s Gold Medal, the Queen’s Jubilee Medal, the Meritorious Service Medal, and in 2011 was inducted as a Fellow of the Royal Society of Canada. He holds the Canada Research Chair in Transplant Surgery and Regenerative Medicine and has an honorary doctorate from Uppsala university in Sweden.
James continues to lead the Edmonton team which is by far the most successful and active islet transplant program worldwide.
Canadian Friends of the Hebrew University of Jerusalem and Jewish National Fund are leading the way in scientific research and development, laboratory equipment and student scholarships enabling further research that can benefit the international community.
The Arava Research & Development Centre – Biotechnology & Medicinal Plant Laboratory
Established in 1986, the Yair Research and Development station at Moshav Hatseva in the central Arava forms part of the network of agricultural R&D stations developed and supported by JNF. The expansion of the station’s facilities plays a significant role in ensuring the region’s development. In recent years, studies have been undertaken in the fields of molecular biology and related disciplines, laying the foundation for developing botanical drugs, with the intention of curing various diseases.
The current facility is at full capacity, making a new wing necessary to accommodate postgraduate students and scientists, both from Israel and abroad, hoping to join the R&D team. The project involves providing infrastructure for and the construction of an additional facility to house laboratories and relevant office space in addition to new laboratory equipment.
Institute Of Medical Research Israel-Canada (Imric) – Collaboration Between Dr. Shapiro & Dr. Dor
This IMRIC collaboration partners Hebrew University’s Dr. Yuval Dor with the University of Alberta’s Dr. James Shapiro, Director of the Clinical Islet Transplant Program.
Diabetes occurs when beta cells in the pancreas produce insufficient insulin. Dr. Shapiro, a leading figure in the clinical treatment of diabetes, designed the Edmonton Protocol for transplanting insulin-producing beta cells into the pancreas of a person living with diabetes. Dr. Dor’s research at IMRIC determined that by eliminating a specific gene, called LKB1, from the beta cell, we can increase production and secretion of more insulin.
This IMRIC collaboration could pave the way for radical new diabetes treatment.
AMBASSADOR IDO AHARONI
CONSUL GENERAL OF ISRAEL IN NEW YORK
Ido Aharoni has been a member of Israel’s Foreign Service since 1991. He served as Consul for Media and Public Affairs at the Consulate General of Israel in New York prior to the terror attacks of 9/11. As the head of the department, Aharoni oversaw the operation of Israel’s largest public affairs and media relations apparatus worldwide. While in New York, Aharoni became familiar with nation-branding methods, which he later introduced to his superiors in Jerusalem. This effort resulted in bringing about a paradigm shift in the perception of Israel’s public image by Israeli officials, in Israel and in the USA.
In February 2011, he officially assumed the post of Consul General of Israel in New York, after serving as Acting Consul General since August 2010. As Consul General, he represents the State of Israel to communities from throughout the tri-state areas of New York, New Jersey and Connecticut.
Dr. Errol Raff
CHIEF EXECUTIVE OFFICER
JNF EDMONTON PRESIDENT
JNF EDMONTON OFFICE
Devorah Matkovcik • Miriam Cooper
Sponsorship & Tribute Opportunities
When & Where
Thursday, June 23, 2016
Reception at 5:30pm – Programme at 7pm
Timms Centre for the Arts – University of Alberta
Kashrut Observed – Dessert reception to follow
For further information:
Devorah Matkovcik, Office Administrator
Tel: (780) 481-7881
Fax: (780) 487-4747
10220-156 St S.W